204 related articles for article (PubMed ID: 4123828)
1. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
McKenzie IF; Snell GD
J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
[TBL] [Abstract][Full Text] [Related]
2. Cross reactivity between H-2K and H-2D products. III. Effect of H-2K-H-2D cross sensitization on skin graft survival.
Murphy DB; Shreffler DC
Transplantation; 1975 Jul; 20(1):38-44. PubMed ID: 52220
[TBL] [Abstract][Full Text] [Related]
3. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
4. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
Klein J; Geib R; Chiang C; Hauptfeld V
J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
[TBL] [Abstract][Full Text] [Related]
5. The H-2 complex: immunogenicity and enhancement studies of H-2K region alloantigens.
McKenzie IF; Henning MM
J Immunogenet; 1977 Aug; 4(4):249-57. PubMed ID: 334998
[No Abstract] [Full Text] [Related]
6. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
Billings P; Burakoff S; Dorf ME; Benacerraf B
J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
[TBL] [Abstract][Full Text] [Related]
7. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
Brondz BD; Egorov IK; Drizlikh GI
J Exp Med; 1975 Jan; 141(1):11-26. PubMed ID: 46906
[TBL] [Abstract][Full Text] [Related]
8. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
Brondz BD; Egorov IK
Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
[No Abstract] [Full Text] [Related]
9. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;
Zinkernagel RM; Doherty PC
J Exp Med; 1975 Jun; 141(6):1427-36. PubMed ID: 47901
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
[TBL] [Abstract][Full Text] [Related]
11. Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse.
Klein J; Shreffler DC
J Exp Med; 1972 Apr; 135(4):924-37. PubMed ID: 4553015
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivity.
Murphy DB; Shrefler DC
J Exp Med; 1975 Feb; 141(2):374-91. PubMed ID: 1089744
[TBL] [Abstract][Full Text] [Related]
13. Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma.
Meschini A; Invernizzi G; Parmiami G
Int J Cancer; 1977 Aug; 20(2):271-83. PubMed ID: 70414
[TBL] [Abstract][Full Text] [Related]
14. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
[TBL] [Abstract][Full Text] [Related]
15. Comparison of skin allograft rejection and cytotoxic antibody production in two lines of mice genetically selected for "high" and "low" antibody synthesis.
Liacopoulos-Briot M; Bouthillier Y; Mouton D; Lambert F; Decreusefond C; Stiffel C; Biozzi G
Transplantation; 1972 Nov; 14(5):590-6. PubMed ID: 4563199
[No Abstract] [Full Text] [Related]
16. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.
Schmitt-Verhulst AM; Shearer GM
J Exp Med; 1976 Dec; 144(6):1701-6. PubMed ID: 1087329
[TBL] [Abstract][Full Text] [Related]
17. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.
Tashiro-Yamaji J; Einaga-Naito K; Kubota T; Yoshida R
Microbiol Immunol; 2006; 50(2):105-16. PubMed ID: 16490928
[TBL] [Abstract][Full Text] [Related]
18. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
Berden JH; Gerlag PG; Hagemann JF; Koene RA
Transplantation; 1977 Sep; 24(3):175-82. PubMed ID: 339430
[TBL] [Abstract][Full Text] [Related]
19. Serological cross-reaction between H-2D and H-2K region antigens.
David CS; Shreffler DC; Murphy DB; Klein J
Transplant Proc; 1973 Mar; 5(1):287-93. PubMed ID: 4572101
[No Abstract] [Full Text] [Related]
20. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
Drizlikh G; Schmidt-Sole J; Yankelevich B
J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
